Friday, October 06, 2017

Bayer invests US $100 million in u.s. biotech company

São Paulo, 5/10-Bayer will invest $ $100 million on American company of biotechnology and Ginkgo Bioworks enzymes to create a company focused on improving the ability of microorganisms of nitrogen fixing plants, reported the German in note. The new company will split your thirst with Ginkgo in Boston and in West Sacramento, in the U.S. State of California, where the Head Office of research and development at Bayer biological products.
According to the statement, the greater part of agricultural crops can''t combine with microorganisms that live within the plants to meet their needs for nitrogen, with the exception of soy, peas and legumes.
The company plans to develop micro-organisms that help plants on nutrient fixation. The closing of the transaction is subject to customary conditions and must occur by the end of 2017.
ISTOÉ – 05/10/2017
Related products
News Item translated automatically
Click HERE to see original
Other news
DATAMARK LTDA. © Copyright 1998-2022 ®All rights reserved.Av. Brig. Faria Lima,1993 third floor 01452-001 São Paulo/SP